Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Catherine P. Leith"'
Autor:
Meghan B. Brennan, Barbara L. Herwaldt, James J. Kazmierczak, John W. Weiss, Christina L. Klein, Catherine P. Leith, Rong He, Matthew J. Oberley, Laura Tonnetti, Patricia P. Wilkins, Gregory M. Gauthier
Publikováno v:
Emerging Infectious Diseases, Vol 22, Iss 11, Pp 1869-1876 (2016)
Babesia microti, an intraerythrocytic parasite, is tickborne in nature. In contrast to transmission by blood transfusion, which has been well documented, transmission associated with solid organ transplantation has not been reported. We describe para
Externí odkaz:
https://doaj.org/article/8655ad60959d4988869f73569a1c00ad
Autor:
Shigeki Miyamoto, KyungMann Kim, Brad S. Kahl, Catherine P. Leith, Martha Raschko, Jae E. Werndli, Jihoon Kim, Shelby L. O'Connor, Natalie S. Callander, Stephanie Markovina
Supplementary Figure S1 from Bortezomib-Resistant Nuclear Factor-κB Activity in Multiple Myeloma Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::504d62c5cb6098164550e36ec9f1dc35
https://doi.org/10.1158/1541-7786.22518933
https://doi.org/10.1158/1541-7786.22518933
Autor:
Shigeki Miyamoto, KyungMann Kim, Brad S. Kahl, Catherine P. Leith, Martha Raschko, Jae E. Werndli, Jihoon Kim, Shelby L. O'Connor, Natalie S. Callander, Stephanie Markovina
Bortezomib (Velcade/PS341), a proteasome inhibitor used in the treatment of multiple myeloma (MM), can inhibit activation of nuclear factor-κB (NF-κB), a family of transcription factors often deregulated and constitutively activated in primary MM c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cf0155fe6051fd3438809e4e68ac0dd
https://doi.org/10.1158/1541-7786.c.6542187.v1
https://doi.org/10.1158/1541-7786.c.6542187.v1
Autor:
Byron, Barksdale, Catherine P, Leith
Publikováno v:
Blood. 136(14)
Autor:
Charles M. Leys, Peter F. Nichol, Kara G. Gill, Ankush Gosain, Darya Buehler, Mohamed Y. Elsaid, Catherine P. Leith, Neha Patel
Publikováno v:
Journal of Pediatric Hematology/Oncology. 39:e399-e402
Coincidence of renal cell carcinoma (RCC) and hematologic malignancies has been reported in adults but not in children.We report a case of a 16-year-old girl in whom RCC was incidentally discovered on the computed tomography scan that was performed t
Autor:
Catherine P. Leith, Peiman Hematti, Athanasios Papadas, Natalie S. Callander, Parameswaran Hari, Muhammad Umair Mushtaq, Ashley M. Cunningham, Binod Dhakal, Chelsea Hope, Zachary Morrow, Evan Flietner, Fotis Asimakopoulos, Adam Pagenkopf
Publikováno v:
Leuk Lymphoma
High-dose alkylator-based conditioning followed by autologous stem-cell transplantation (ASCT) is a therapeutic mainstay for eligible patients with multiple myeloma. However, post-transplant relapses are common and prognostic biomarkers are scarce. R
Autor:
Erik A. Ranheim, Richard K. Yang, Catherine P. Leith, Sanjay S. Patel, Moniba Nazeef, David T. Yang, Ryan J. Mattison
Publikováno v:
International journal of laboratory hematology. 40(4)
INTRODUCTION Bone marrow biopsy (BMB) is crucial for the diagnosis, staging, and monitoring of a variety of hematologic diseases. Obtaining an adequate BMB can be challenging given the need to balance patient comfort with acquisition of high quality
Autor:
Catherine P. Leith
Publikováno v:
Clinics in laboratory medicine. 37(4)
Cost-effective flow cytometry (FC) requires development of FC panels focused to common diagnoses and strategies to identify cases where limited FC testing is sufficient. Focused panels include sufficient antibodies and to identify common diseases and
Autor:
Sean A. Fitzgerald, Catherine P. Leith, Joyce Johnson, Matthew J. Oberley, David T. Yang, Adam Morgan
Publikováno v:
American Journal of Clinical Pathology. 142:411-418
Objectives: Flow cytometry is essential for the evaluation of lymphoproliferative disorders (LPDs) and their classification. Flow panels routinely incorporate a large array of antibodies, making testing complex and expensive; such panels are likely u
Autor:
Catherine P. Leith, Natalie S. Callander, P. Leif Bergsagel, Ioanna G. Maroulakou, Erika Heninger, Jaehyup Kim, Shigeki Miyamoto, Peiman Hematti, Marta Chesi, Chelsea Hope, Samuel J. Ollar, David T. Yang, Jeffrey L. Jensen, Ellen Hebron, Fotis Asimakopoulos
Publikováno v:
Blood. 123:3305-3315
Targeted modulation of microenvironmental regulatory pathways may be essential to control myeloma and other genetically/clonally heterogeneous cancers. Here we report that human myeloma-associated monocytes/macrophages (MAM), but not myeloma plasma c